Luminar Media Group (OTC: LRGR) shares are up 7% after the company, in conjunction with The Jenex Corporation, this morning reported the completion of a working prototype for the patent-pending TherOZap™ device. Additionally, the University Health Network has entered an agreement to test Therozap™ against the Zika and West Nile viruses. “The availability of a working prototype brings us one step closer to releasing this product to market. Expanding the device’s effectiveness to the Zika and West Nile virus will provide tremendous benefit for many regions of the world,” CEO and chairman of Luminar Chris Cook stated in the news release.
To view the full press release, visit: http://nnw.fm/DEbv9
About Luminar
The Luminar Media Group is engaged in the media, marketing and entertainment industries. Luminar will bring its experience to the TherOZap trade name and is developing a global marketing strategy. Initial efforts will focus on launching its innovative therapy device in the United States with additional markets to follow closely. The company was started by entrepreneurs who can identify new tools to communicate with a target audience. The company embraces the challenge of the constantly evolving business landscape and develops solutions that evolve with the changing business paradigm. If you would like to stay informed on the development of TherOZap™ please visit www.therozap.com.
About NetworkNewsBreak
NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
